PROFIL
Luca GRUMOLATO
ÉQUIPE : Plasticité et Physiopathologie Neuroendocrine
E-MAIL : luca.grumolato@univ-rouen.fr
STATUT : Maître de conférences des universités
ORCID : 0000-0001-8231-3032
After a Master’s degree in Molecular Biology from the University of Torino (Italy), Luca Grumolato obtained a Ph.D. in Cell Biology at the University of Rouen. He then moved to New York for his postdoctoral studies in Stu Aaronson’s lab, where he worked on the role of Wnt signaling in cancer.
In 2011, Luca was awarded a Chair of Excellence from Inserm and the University of Rouen and he joined the DC2N (now NorDiC) laboratory. Since 2022, Luca is co-director of the PPN team. His group is interested in cancer targeted therapies and, more specifically, in how intratumor heterogeneity drives drug resistance.